BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2801838)

  • 1. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of c-ras-Ki oncogene in human ovarian tumours.
    Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML
    Int J Cancer; 1989 Mar; 43(3):428-30. PubMed ID: 2925274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
    Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
    Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.
    Yoshida K; Tsuda T; Matsumura T; Tsujino T; Hattori T; Ito H; Tahara E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(5):285-90. PubMed ID: 2570489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
    Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
    J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.
    Filmus JE; Buick RN
    Cancer Res; 1985 Sep; 45(9):4468-72. PubMed ID: 4028028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
    Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene alterations in primary human colon tumors.
    Alexander RJ; Buxbaum JN; Raicht RF
    Gastroenterology; 1986 Dec; 91(6):1503-10. PubMed ID: 2876925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of ras oncogenes in primary human cancers.
    Feinberg AP; Vogelstein B
    Biochem Biophys Res Commun; 1983 Feb; 111(1):47-54. PubMed ID: 6187346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Ki-ras oncogene in human prostatic adenocarcinoma.
    Peehl DM; Wehner N; Stamey TA
    Prostate; 1987; 10(4):281-9. PubMed ID: 3601807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
    Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
    Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus.
    Galiana C; Lozano JC; Bancel B; Nakazawa H; Yamasaki H
    Mol Carcinog; 1995 Dec; 14(4):286-93. PubMed ID: 8519418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.